End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
834 INR | +0.73% | +0.08% | +26.93% |
May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
Apr. 25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- GLS Stock
- Revisions Glenmark Life Sciences Limited